Summary of the contracting process

The University of Edinburgh is inviting tenders for the "Genome Plasmid" project within the education industry category. The procurement process is currently in the tender stage, with the tender closing on 1st July 2025 at 16:00 GMT. The need is for a plasmid manufactured to FDA, IND ready standards to advance clinical trials addressing a genetic disease in children. Although the buyer is based in Edinburgh, the products will be delivered to a partner located in Los Angeles, USA, enhancing international collaboration. This open procurement is seeking electronic submissions and promises a contract valued at £62,000 GBP.

This tender provides a significant opportunity for businesses specialising in biomedical manufacturing, particularly those with a track record of supplying FDA-approved products for clinical trials. Companies experienced in quality management systems compliant with Good Manufacturing Practice (GMP) will be well-suited to compete for this contract. The potential for additional orders through a negotiated procedure without prior call for competition offers room for business growth. Suppliers will gain visibility and strengthen their international presence, especially in the USA, where they can leverage past successes in acquiring FDA approvals.

Tender

Genome Plasmid

UNIVERSITY OF EDINBURGH

Contract Timeline

Publication Date

17th June 2025 00:00:00 AM

Tender Deadline

1st July 2025 16:00:00 PM Expired
Contract Summary

We are planning a clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy is based on the following: Autologous haematopoietic stem progenitor cells (HSPCs) are modified ex vivo with a lentiviral vector (LV) to express supraphysiologic levels of a secreted enzyme in myeloid progeny, in essence using gene-modified monocytes/macrophages as a durable and effective vehicle for central nervous system (CNS) enzyme delivery. In order to progress this therapy, we require the following; a plasmid to our specification, produced to FDA, IND ready standard for use in the manufacture of a lentiviral vector for clinical trial. This Plasmid will be delivered directly from the supplier to the University of Edinburghâs partner in the project, University of California Los Angeles.
Contract Details

Open Contracting ID

ocds-r6ebe6-0000801998

Publication Source

Public Contracts Scotland

Procurement Stage

Tender

Procurement Method

Open

Procurement Method Details

Open Procedure

Procurement Category

Goods

Tender Suitability

Framework / DPS
Contract Classification

CPV Code(s)

33140000

CPV Division(s)

33 - Medical equipments, pharmaceuticals and personal care products
Awarding Authority

UNIVERSITY OF EDINBURGH

Buyer Name

Buyer Email

jpike2@ed.ac.uk

Buyer Phone

+44 1316502759

Buyer Address

Charles Stewart House, 9-16 Chambers Street

Edinburgh

EH1 1HT

View contract on Public Contracts Scotland

Genome Plasmid

UNIVERSITY OF EDINBURGH

Contract Timeline

Contract Summary

Contract Details

Contract Classification

Awarding Authority